7Ohta M, Inoue H, Cotticelli MG. et al. The fhit gene spanning the chromosone 3p14.2 fragile site and renal carcinomaassociated t(3, 8) breakpoint, is abnormal in digestive tract cancers [J]. Cell, 1996, 84(4):587-597.
8Baffa R,Gomella LG,Vecchione A,et al. Loss of Fhit expression in transition cell carcinoma of the urinary bladder [J]. Am J Pathol, 2000,156(2) :419-424.
9Kastritis E,Murray S,Kyriakou F,et al.Somatic mutations of adenomatous polyposis coli gene and nuclear b-catenin accumulation have prognostic significance in invasive urothelial carcinomas:evidence for Wnt pathway implication[J].Int J Cancer,2009,124(1):103-108.
10Christoph F,Kempkensteffen C,Weikert S,et al.Methylation of tumour suppressor genes APAF-1 and DAPK-1 and in vitro effects of demethylating agents in bladder and kidney cancer[J].Br J Cancer,2006,95(12):1701-1707.
4Singh PK, Srivastava AK, Dalela D, et al. Frequent expression of zinc-finger protein ZNF165 in human urinary bladder transitional cell carcinoma[J]. Immunobiology, 2015,220(1):68-73.
5van Rhijn BW, Catto JW, Goebell PJ, et al. Molecular markers for urothelial bladder cancer prognosis: toward implementation in clinical practice[J]. Urol Oncol, 2014,32(7):1078-1087.
6Kim MS, Je EM, Oh JE, et al. Mutational and expressional analyses of SPOP, a candidate tumor suppressor gene, in prostate, gastric andcolorectal cancers[J]. APMIS, 2013,121(7):626-633.
7Kim B, Nam HJ, Pyo KE, et al. Breast cancer metastasis suppressor 1 (BRMS1) is destabilized by the Cul3-SPOP E3 ubiquitin ligase complex[J]. Biochem Biophys Res Commun, 2011,415(4):720-726.
8Li G, Ci W, Karmakar S, et al. SPOP promotes tumorigenesis by acting as a key regulatory hub in kidney cancer[J]. Cancer Cell, 2014,25(4):455-468.
9Kulkarni P, Shiraishi T, Rajagopalan K, et al. Cancer/testis antigens and urological malignancies[J]. Nat Rev Urol, 2012,9(7):386-396.
10Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013 [J]. CA Cancer J Clin, 2013, 63(1):11-30.
